(E)-3-(2-((5-(3-(phenylsulfonamido)phenyl)pent-4-en-1-yl)oxy)phenyl)propanoic acid
CIPN - Chemotherapy-Induced Peripheral Neuropathy
Ono Pharmaceutical Co., Ltd.Small moleculePhase 2Active
B
57/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 42/ 100
- Competitive Position
- 95/ 100
Competitive context
29 Active assets in the CIPN - Chemotherapy-Induced Peripheral Neuropathy cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Pregabalin University of Rochester | Phase 4 | BB |
Omeprazole Aya Mohamed Sadek Elsaid | Phase 3 | BB |
LIDOCAINE Hospital Ambroise Paré Paris | Phase 2 | BB |
Mecobalamin Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh | Phase 2/3 | B |
Vitamin B6 Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh | Phase 2/3 | B |
View all 46 →
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →